InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the full record of transactions filed by Iwicki Mark T, Director. Officer active across 2 companies, notably Akero Therapeutics, Inc.. Aggregated, 9 filings have been published. Total volume traded: €184k. The latest transaction was disclosed on 27 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations9 total
9,398 shares
Common Stock
SEC:0001193125-25-312115·
9,398 shares
Common Stock
SEC:0001193125-25-312115:0·
€2,7897,975 shares@ €0.34970.018% mcap1.5% of flow
Common Stock
SEC:0001415889-22-007059:0·
€10,9489,518 shares@ €1.150212.1% of flow
Common Stock
SEC:0001415889-22-000402·
€10,9489,518 shares@ €1.15020.071% mcap6.0% of flow
Common Stock
SEC:0001415889-22-000402:0·
€42,83127,598 shares@ €1.55247.3% of flow
Common Stock
SEC:0001415889-21-005009·
€42,83127,598 shares@ €1.5520.28% mcap23.3% of flow
Common Stock
SEC:0001415889-21-005009:0·
€36,6937,586 shares@ €4.83740.6% of flow
Common Stock
SEC:0001415889-21-003256·
€36,6937,586 shares@ €4.8370.24% mcap20.0% of flow
Common Stock
SEC:0001415889-21-003256:0·
9 of 9 declarations
About Iwicki Mark T
Iwicki Mark T is the Chief Executive Officer of Akero Therapeutics, Inc. and Kala Pharmaceuticals, Inc. He leads the strategic and operational activities of these companies, focusing on innovation and growth. With a strong background in the pharmaceutical sector, he is responsible for formulating business strategies and overseeing the executive teams. His leadership is essential for achieving the company’s objectives and ensuring value creation for shareholders.
